tygacil
pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - antibacterials za sistemsko uporabo, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti. ustrezno uporabo protibakterijsko agenti.
rabadrop (safeguard)
bioveta -
cefenil rtu
norbrook laboratories (ireland) ltd -
solamocta
eurovet animal health bv handelsweg 25 -
amoksicilin belupo 1000 mg disperzibilne tablete
amoksicilin - disperzibilna tableta - amoksicilin 1000 mg / 1 tableta - amoksicilin
amoksicilin belupo 500 mg disperzibilne tablete
amoksicilin - disperzibilna tableta - amoksicilin 500 mg / 1 tableta - amoksicilin
doksivibra 100 mg disperzibilne tablete
pfizer luxembourg sarl - doksiciklin - disperzibilna tableta - doksiciklin 100 mg / 1 tableta - doksiciklin
doxybactin
dechra regulatory -
doksivibra 100 mg disperzibilne tablete
pfizer luxembourg sarl - doksiciklin - disperzibilna tableta - doksiciklin 100 mg / 1 tableta - doksiciklin
doxybactin 15-50-200-400 mg tabl - dcp